The modulation of JNK signalling by WNT5A-ROR2, together with Aβ and DKK1, highlights the need to understand better the intertwined pathway interactions to develop targeted therapeutic strategies for AD. This evidence concerns the gene MAPK8 and Alzheimer disease.